Vol. 14. Núm. 29.
Páginas 1775-1780 (Marzo 2025)

Protocolos de práctica asistencial
Protocolo diagnóstico y terapéutico de la esofagitis eosinofílica

Diagnostic and treatment protocol for eosinophilic esophagitis

I. Roibás VeigaaP. Méndez BreaaT. González VidalbC. Vidal Pana
Doi : https://10.1016/j.med.2025.04.008
Opciones
Resumen

Se presenta un protocolo diagnóstico y terapéutico para la esofagitis eosinofílica (EoE), una enfermedad inflamatoria crónica del esófago mediada por una respuesta inmunitaria tipo 2. Se establecen criterios clínicos, endoscópicos e histopatológicos para un diagnóstico preciso y se definen estrategias terapéuticas que incluyen inhibidores de la bomba de protones, corticosteroides tópicos, dietas de eliminación y, en casos refractarios, terapia biológica. Además, se destacan biomarcadores emergentes y se enfatiza la importancia de la monitorización endoscópica y funcional para prevenir complicaciones fibroestenóticas y optimizar la respuesta terapéutica.

Palabras clave
Eosinófilos
Disfagia
Biopsia esofágica
Inhibidores bomba protones
Corticoides deglutidos
Dietas de eliminación
Abstract

A diagnostic and therapeutic protocol for eosinophilic esophagitis (EoE), a chronic inflammatory disease of the esophagus driven by a type 2 immune response, is presented. This protocol establishes precise clinical, endoscopic, and histopathological criteria for diagnosis and outlines a stepwise treatment approach, including proton pump inhibitors, topical corticosteroids, elimination diets, and biologic therapy for refractory cases. Additionally, emerging biomarkers are highlighted, and the importance of endoscopic and functional monitoring is emphasized to prevent fibrostenotic complications and optimize therapeutic outcomes.

Keywords
Eosinophils
Dysphagia
Esophageal biopsy
Proton-pump inhibitors
Swallowed corticosteroids
Elimination diets

Identifíquese

¿Aún no es suscriptor de la revista?

Comprar el acceso al artículo

Comprando el artículo el pdf del mismo podrá ser descargado

Teléfono para incidencias

De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h

Llamadas desde España 932 415 960
Llamadas desde fuera de España +34 932 415 960
Bibliografía
[1]
A. Papadopoulou
202504141240060828
, J. Amil-Dias, M.K.-H. Auth, M. Chehade, M.H. Collins, S.K. Gupta, et al.
Joint ESPGHAN/NASPGHAN Guidelines on childhood eosinophilic gastrointestinal disorders beyond eosinophilic esophagitis.
J Pediatr Gastroenterol Nutr., (2024), 78 pp. 122-152
[2]
E. La Orden Izquierdo
202504141240060829
, C. Gutiérrez Junquera, I. Mahillo-Fernández, J. Subiza Garrido-Lestache, E. Román Riechmann.
Increasing Incidence of pediatric eosinophilic esophagitis in the southwest of Madrid, Spain.
J Investig Allergol Clin Immunol., (2019), 29 pp. 249
[3]
A.R. Gratacós Gómez
2025041412400608210
, S.F. Ortega, A.P. Cañas, F.F. Brito, J.R. Muñoz Rodriguez, E.G. Torrijos.
Impact of environmental factors on the epidemiology of eosinophilic esophagitis in southwestern Europe (2007-2020).
J Allergy Clin Immunol Glob., (2023), 2 pp. 100088
[4]
R. García Rodríguez
2025041412400608211
, Y. Méndez Díaz, L. Moreno Lozano, A. Extremera Ortega, E. Gómez Torrijos.
Eosinophilic esophagitis after egg oral immunotherapy in an adult with egg-allergy and egg-bird syndrome.
J Investig Allergol Clin Immunol., (2017), 27 pp. 266-267
[5]
E.G. Torrijos
2025041412400608212
.
Food oral immunotherapy and eosinophilic esophagitis: Complication or comorbidity?.
ADT., (2023), 6 pp. 1-4
[6]
A.R. Gratacós Gómez
2025041412400608213
, E. Gómez Torrijos.
Eosinophilic esophagitis due to aeroallergens: A systematic review and update.
J Investig Allergol Clin Immunol., (2022), 32 pp. 438-450
[7]
Y. Kinoshita
2025041412400608214
, S. Oouchi, T. Fujisawa.
Eosinophilic gastrointestinal diseases - Pathogenesis, diagnosis, and treatment.
Allergol Int., (2019), 68 pp. 420-429
[8]
S. Khan
2025041412400608215
, X. Guo, T. Liu, M. Iqbal, K. Jiang, L. Zhu, et al.
An update on eosinophilic esophagitis: Etiological factors, coexisting diseases, and complications.
Digestion., (2021), 102 pp. 342-356
[9]
A.R. Gratacós Gómez
2025041412400608216
, S.F. Ortega, A.P. Cañas, F.F. Brito, J.R. Muñoz Rodriguez, E.G. Torrijos.
Impact of environmental factors on the epidemiology of eosinophilic esophagitis in southwestern Europe (2007-2020).
J Allergy Clin Immunol Glob., (2023), 2 pp. 100088
[10]
P. Kaur
2025041412400608217
, R. Chevalier, C. Friesen, J. Ryan, A. Sherman, S. Page.
Diagnostic role of fractional exhaled nitric oxide in pediatric eosinophilic esophagitis, relationship with gastric and duodenal eosinophils.
World J Gastrointest Endosc., (2023), 15 pp. 407-419
[11]
M.J. Lanz
2025041412400608218
, R.A. Guerrero, R. Gonzalez-Vallina.
Measurement of exhaled nitric oxide in the evaluation for eosinophilic esophagitis in children.
Ann Allergy Asthma Immunol., (2012), 109 pp. 81-82
[12]
E. Gómez Torrijos
2025041412400608219
, A. Castro Jimenez, A. Gratacós Gómez, O. González Jimenez, J. Joyanes Romo, F. Feo Brito, et al.
Are the proton pump inhibitor–responsive and –nonresponsive phenotypes of eosinophilic esophagitis exactly the same?.
J Investig Allergol Clin Immunol., (2021), 31 pp. 441-442
[13]
M. Sebastian-Delacruz
2025041412400608220
, K. Garcia-Etxebarria, J.R. Bilbao, A.J. Lucendo, L. Bujanda, A. Castellanos-Rubio.
A novel, noninvasive method to diagnose active eosinophilic esophagitis, combining clinical data and oral cavity RNA levels.
Clin Gastroenterol Hepatol., (2024), 22
[14]
E. Gómez Torrijos
2025041412400608221
, P. Sánchez Miranda, P. Donado Palencia, A. Castro Jimenez, J. Rodriguez Sánchez, Y. Mendez Díaz, et al.
eosinophilic esophagitis: demographic, clinical, endoscopic, histologic, and atopic characteristics of children and teenagers in a region in central spain.
J Investig Allergol Clin Immunol., (2017), 27 pp. 104-110
[15]
A.R. Gratacós Gómez
2025041412400608222
, J.V. Meneses Sotomayor, J.B. Joyanes Romo, A. Palacios Cañas, L. Gonzalez Lopez, E. Gomez Torrijos.
Symptoms and complications that require urgent treatment and upper digestive comorbidities in eosinophilic esophagitis.
Dig Liver Dis., (2022), 54 pp. 842-844
[16]
E.C. Steinbach
2025041412400608223
, M. Hernandez, E.S. Dellon.
Eosinophilic esophagitis and the eosinophilic gastrointestinal diseases: Approach to diagnosis and management.
J Allergy Clin Immunol Pract., (2018), 6 pp. 1483-1495
[17]
A.J. Lucendo
2025041412400608224
2025041412400608225
, J. Molina-Infante, Á. Arias, U. von Arnim, A.J. Bredenoord, C. Bussmann, et al.
Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults.
United European Gastroenterol J., (2017), 5 pp. 335-358
[18]
B. Lazarus
2025041412400608226
, Y. Chen, F.P. Wilson, Y. Sang, A.R. Chang, J. Coresh, et al.
Proton pump inhibitor use and the risk of chronic kidney disease.
JAMA Intern Med., (2016), 176 pp. 238-246
[19]
Y. Kinoshita
2025041412400608227
, N. Ishimura, S. Ishihara.
Advantages and disadvantages of long-term proton pump inhibitor use.
J Neurogastroenterol Motil., (2018), 24 pp. 182-196
[20]
N. Ishimura
2025041412400608228
, Y. Kinoshita.
Eosinophilic esophagitis in Japan: Focus on response to acid suppressive therapy.
J Gastroenterol Hepatol., (2018), 33 pp. 1016-1022
[21]
J.P. Franciosi
2025041412400608229
, M. Gordon, V. Sinopoulou, E.S. Dellon, S.K. Gupta, C.C. Reed, et al.
Medical treatment of eosinophilic esophagitis.
Cochrane Database Syst Rev., (2023), 7 pp. CD004065
[22]
A. Gómez-Aldana
2025041412400608230
, M. Jaramillo-Santos, A. Delgado, C. Jaramillo, A. Lúquez-Mindiola.
Eosinophilic esophagitis: Current concepts in diagnosis and treatment.
World J Gastroenterol., (2019), 25 pp. 4598-4613
[23]
M. Chehade
2025041412400608231
, E.S. Dellon, J.M. Spergel, M.H. Collins, M.E. Rothenberg, R.D. Pesek, et al.
Dupilumab for eosinophilic esophagitis in patients 1 to 11 years of age.
N Engl J Med., (2024), 390 pp. 2239-2251